Sartorius Stedim Biotech SA Cash Flow Reinvestment Rate
Sartorius Stedim Biotech SA cash flow reinvestment rate. Sartorius Stedim Biotech SA (DIM) has a Cash Flow Reinvestment Rate of 0.56x as of June 2026, reinvesting €72.80 Million (capex €72.80 Million ) from operating cash flow of €129.50 Million. See DIM free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sartorius Stedim Biotech SA (2005–2025)
Cash flow reinvestment rate of Sartorius Stedim Biotech SA from 2005 to 2025. Historical reinvestment intensity for Sartorius Stedim Biotech SA across 21 annual periods. Explore Sartorius Stedim Biotech SA (DIM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sartorius Stedim Biotech SA Cash Flow Reinvestment Rate by Year (2005–2025)
Sartorius Stedim Biotech SA cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for Sartorius Stedim Biotech SA. For the full cash flow conversion analysis, see Sartorius Stedim Biotech SA operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €397.60 Million | €538.60 Million | €393.20 Million | ▼ -11.5% |
| 2024 | 0.83x | €679.80 Million | €815.10 Million | €339.80 Million | ▼ -80.8% |
| 2023 | 4.35x | €3.24 Billion | €746.40 Million | €473.60 Million | ▲ +91.7% |
| 2022 | 2.27x | €1.39 Billion | €612.30 Million | €430.60 Million | ▲ +99.9% |
| 2021 | 1.13x | €789.21 Million | €695.97 Million | €323.99 Million | ▼ -39.4% |
| 2020 | 1.87x | €780.31 Million | €416.88 Million | €159.19 Million | ▲ +80.9% |
| 2019 | 1.03x | €320.87 Million | €310.13 Million | €135.97 Million | ▼ -33.4% |
| 2018 | 1.55x | €353.08 Million | €227.29 Million | €176.54 Million | ▼ -15.7% |
| 2017 | 1.84x | €321.75 Million | €174.69 Million | €126.83 Million | ▲ +58.2% |
| 2016 | 1.16x | €182.45 Million | €156.66 Million | €79.71 Million | ▲ +213.8% |
| 2015 | 0.37x | €52.98 Million | €142.79 Million | €52.98 Million | ▼ -12.2% |
| 2014 | 0.42x | €47.07 Million | €111.31 Million | €47.07 Million | ▲ +30.1% |
| 2013 | 0.32x | €29.28 Million | €90.11 Million | €29.28 Million | ▼ -59.0% |
| 2012 | 0.79x | €38.78 Million | €48.93 Million | €38.78 Million | ▲ +24.6% |
| 2011 | 0.64x | €38.55 Million | €60.59 Million | €38.55 Million | ▲ +177.5% |
| 2010 | 0.23x | €16.68 Million | €72.76 Million | €16.68 Million | ▲ +31.3% |
| 2009 | 0.17x | €16.05 Million | €91.86 Million | €16.05 Million | ▼ -59.2% |
| 2008 | 0.43x | €20.23 Million | €47.23 Million | €20.23 Million | ▼ -18.5% |
| 2007 | 0.53x | €13.68 Million | €26.02 Million | €13.68 Million | ▼ -12.9% |
| 2006 | 0.60x | €31.21 Million | €51.72 Million | €31.21 Million | ▲ +91.9% |
| 2005 | 0.31x | €13.79 Million | €43.85 Million | €13.79 Million | — |